Lappe Mark

Lappe Mark, Chief Executive Officer, Director, accounts for 1 disclosed filing worth $2.6M, all concentrated in Inhibrx Biosciences, Inc. (INBX), active 2026. The record is heavily weighted toward buying, with $2.6M in purchases against $0 in sales. The largest single open-market purchase on record is $2.6M in Inhibrx Biosciences, Inc.. Data is sourced from official SEC Form 3, 4, and 5 filings.